Capital Cell

Capital Cell is Europe's first equity crowdfunding platform dedicated to biotechnology and life sciences companies. Founded in 2014 in Barcelona, Spain, it connects investors with innovative biotech startups seeking funding. The platform offers a diverse range of investment opportunities, allowing both individual and institutional investors to participate in the growth of the biotech sector.

Capital Cell's investment strategy focuses on early-stage and growth-stage companies in sectors such as diagnostics, therapeutics, medical devices, and digital health. By leveraging a network of over 3,500 scientists, doctors, and investment experts, the platform meticulously selects promising companies, ensuring that only a small percentage of applicants are featured. This rigorous selection process aims to provide investors with high-impact, high-return opportunities in the life sciences sector.

Since its inception, Capital Cell has facilitated numerous funding rounds, raising significant capital for biotech startups across Europe. The platform's commitment to democratizing access to biotech investments has made it a prominent player in the European crowdfunding landscape, contributing to the advancement of medical science and healthcare innovation.